Clinical Trial Update: Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 study of obeticholic acid in patients with primary biliary cirrhosis completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• Obeticholic acid (obeticholic acid)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: COMPLETED | Results posted: 2017-02-13